HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Name: HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis
License: Public Domain

Zhejiang Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gastric-cancer

gastric cancer, hipec, anti-pd-1 antibody camrelizumab (shr-1210), chemotherapy and surgery

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230403
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.